Young Ah Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Young Ah Lee has a total of 321 co-authors. Here are the top co-authors by number of shared publications:
- Choong Ho Shin
Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
40 shared publications Choong Ho Shin
29 shared publications- Yun Jeong Lee
Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea
22 shared publications Yun Jeong Lee
17 shared publications- Youn-Hee Lim
Department of Public Health, University of Copenhagen, Copenhagen, Denmark
15 shared publications - Yun-Chul Hong
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Environmental Health Center, Seoul National University College of Medicine, Seoul, Republic of Korea; Institute of Environmental Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea
15 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Springer Nature in Lipids in Health and Disease
Age-specific associations between childhood per- and polyfluoroalkyl substances exposure and blood lipid profiles: a prospective birth cohort study
Background: Per- and polyfluoroalkyl substances (PFAS) are persistent synthetic chemicals detected in populations, including children, through exposure from food, drinking water, and consumer products. Although growing evidence links PFAS exposure to altered pediatric lipid profiles, few longitudinal studies have determined whether developmental timing during early childhood is more strongly associated with lipid alterations than exposure magnitude. Methods: Serum PFAS concentrations and lipid levels, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG), were measured in 212 children from the Environment and Development of Children cohort at ages 2, 4, 6, and 8 years. Generalized additive mixed models (GAMMs) characterized longitudinal dose–response relationships, tested whether associations varied by exposure age, and whether baseline concentrations at age 2 years were associated with lipid trajectories from ages 2 to 8 years. Age-specific linear regression models (lagged and concurrent) and quantile-based g-computation (q-gcomp) were used to estimate age-specific associations and joint effects of the PFAS mixture on lipid levels at age 8 years. Results: In age-pooled GAMMs at ages 2, 4, 6, and 8 years, exposure-response relationships varied in both shape and direction across PFAS compounds for all lipid outcomes, including linear, non-linear and inverse patterns. Baseline PFAS concentrations at age 2 years were not associated with the rate of age-related change in any lipid outcome from ages 2 to 8 years. By contrast, in age-specific regression models evaluating lipid levels at age 8 years, higher HDL-C was associated with PFAS exposure at ages 6 and 8 years, and most associations remained significant after false discovery rate correction. In q-gcomp analyses, the PFAS mixture was positively associated with HDL-C at age 8 years for exposures measured at ages 6 and 8 years. Conclusion: In age-specific analysis, childhood PFAS exposure was associated with higher HDL-C concentrations, and the strength of this association varied by exposure age rather than corresponding directly to exposure magnitude. These findings suggest that developmental timing should be considered when evaluating the effects of childhood PFAS exposure on blood lipids, and require confirmation in larger longitudinal cohort studies.
- 7 September 2026
- Published by Springer Nature in Lipids in Health and Disease
Open AccessAge-specific associations between childhood per- and polyfluoroalkyl substances exposure and blood lipid profiles: a prospective birth cohort study
Background: Per- and polyfluoroalkyl substances (PFAS) are persistent synthetic chemicals detected in populations, including children, through exposure from food, drinking water, and consumer products. Although growing evidence links PFAS exposure to altered pediatric lipid profiles, few longitudinal studies have determined whether developmental timing during early childhood is more strongly associated with lipid alterations than exposure magnitude. Methods: Serum PFAS concentrations and lipid levels, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG), were measured in 212 children from the Environment and Development of Children cohort at ages 2, 4, 6, and 8 years. Generalized additive mixed models (GAMMs) characterized longitudinal dose–response relationships, tested whether associations varied by exposure age, and whether baseline concentrations at age 2 years were associated with lipid trajectories from ages 2 to 8 years. Age-specific linear regression models (lagged and concurrent) and quantile-based g-computation (q-gcomp) were used to estimate age-specific associations and joint effects of the PFAS mixture on lipid levels at age 8 years. Results: In age-pooled GAMMs at ages 2, 4, 6, and 8 years, exposure-response relationships varied in both shape and direction across PFAS compounds for all lipid outcomes, including linear, non-linear and inverse patterns. Baseline PFAS concentrations at age 2 years were not associated with the rate of age-related change in any lipid outcome from ages 2 to 8 years. By contrast, in age-specific regression models evaluating lipid levels at age 8 years, higher HDL-C was associated with PFAS exposure at ages 6 and 8 years, and most associations remained significant after false discovery rate correction. In q-gcomp analyses, the PFAS mixture was positively associated with HDL-C at age 8 years for exposures measured at ages 6 and 8 years. Conclusion: In age-specific analysis, childhood PFAS exposure was associated with higher HDL-C concentrations, and the strength of this association varied by exposure age rather than corresponding directly to exposure magnitude. These findings suggest that developmental timing should be considered when evaluating the effects of childhood PFAS exposure on blood lipids, and require confirmation in larger longitudinal cohort studies.
- 6 August 2026
- Published by Springer Nature in Endocrine
- Vol. 91 (1)
Genetic characteristics and clinical features of pediatric congenital adrenal hyperplasia in Korea
- 6 August 2026
- Published by Springer Nature in Endocrine
- Vol. 91 (1)
Genetic characteristics and clinical features of pediatric congenital adrenal hyperplasia in Korea
- Open Access
- 5 July 2026
- Published by Wiley in Pediatric Obesity
- Vol. 21 (7) , e70129
Prenatal Bisphenol A Exposure and Sex‐Differentiated Childhood BMI Over Time: A Longitudinal Korean Cohort Study
Background: Prenatal exposure to bisphenol A (BPA), an endocrine‐disrupting chemical, may influence childhood obesity. Evidence on sex‐specific effects remains inconsistent. Methods: We analysed 528 mother–child pairs from a Korean birth cohort. Maternal urinary BPA concentrations were measured during mid‐pregnancy. Children's BMI and BMI Z‐score were assessed at ages 2, 4, 6, 8, and 10 years. Associations were estimated using linear and mixed‐effects models, stratified by sex and adjusted for maternal and child covariates. Results: The mean maternal BPA concentration was 2.3 μg/g creatinine. BPA exposure was positively associated with BMI and BMI Z‐score in boys but negatively associated in girls. At age 10, this divergence was most apparent. Mixed‐effects models showed a 0.13 kg/m 2 (95% CI: 0.01, 0.25) increase in BMI among boys and a 0.20 kg/m 2 (95% CI: −0.32, −0.08) decrease among girls per 1‐unit increase in log‐transformed BPA. Similar patterns were observed for BMI Z ‐score. Conclusions: Prenatal BPA exposure exhibited sexually dimorphic associations with BMI from early childhood to age 10. These findings underscore the importance of considering sex‐specific effects in environmental health research and support policies to reduce BPA exposure during pregnancy.
- 5 July 2026
- Published by Wiley in Pediatric Obesity
- Vol. 21 (7) , e70129
Open AccessPrenatal Bisphenol A Exposure and Sex‐Differentiated Childhood BMI Over Time: A Longitudinal Korean Cohort Study
Background: Prenatal exposure to bisphenol A (BPA), an endocrine‐disrupting chemical, may influence childhood obesity. Evidence on sex‐specific effects remains inconsistent. Methods: We analysed 528 mother–child pairs from a Korean birth cohort. Maternal urinary BPA concentrations were measured during mid‐pregnancy. Children's BMI and BMI Z‐score were assessed at ages 2, 4, 6, 8, and 10 years. Associations were estimated using linear and mixed‐effects models, stratified by sex and adjusted for maternal and child covariates. Results: The mean maternal BPA concentration was 2.3 μg/g creatinine. BPA exposure was positively associated with BMI and BMI Z‐score in boys but negatively associated in girls. At age 10, this divergence was most apparent. Mixed‐effects models showed a 0.13 kg/m 2 (95% CI: 0.01, 0.25) increase in BMI among boys and a 0.20 kg/m 2 (95% CI: −0.32, −0.08) decrease among girls per 1‐unit increase in log‐transformed BPA. Similar patterns were observed for BMI Z ‐score. Conclusions: Prenatal BPA exposure exhibited sexually dimorphic associations with BMI from early childhood to age 10. These findings underscore the importance of considering sex‐specific effects in environmental health research and support policies to reduce BPA exposure during pregnancy.
- Open Access
- 26 May 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (4) , 566-578
Clinical Characteristics and Outcomes of Korean Patients with Lipoid Congenital Adrenal Hyperplasia: An Analysis of Data from the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) Cohort Study
Background: Clinical characteristics and follow-up outcomes were examined in Korean patients with lipoid congenital adrenal hyperplasia (LCAH) enrolled in the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) cohort.Methods: Thirty-one patients (classic LCAH [C-LCAH], n=29; nonclassic LCAH [NC-LCAH], n=2) from 10 centers were included. NC-LCAH was defined by any of the following: 46,XY karyotype with male external genitalia, no fludrocortisone use, or diagnosis after infancy.Results: Median age at diagnosis was 36.5 days (interquartile range [IQR], 14.6 to 120.5); salt-wasting occurred in 58.6% of patients, and skin hyperpigmentation was the most common clinical feature (71%). All C-LCAH patients (STAR variants: p.Q258*/p.Q258* [n=27], p.Q258*/p.Arg182His [n=1], p.Q258*/p.Arg182Cys [n=1]; karyotypes: 46,XX [n=17], 46,XY [n=12]) were diagnosed in infancy with a female phenotype. Among C-LCAH patients with 46,XX, 11 had spontaneous thelarche (median, 11.0 years; IQR, 8.2 to 12.2) and five reached menarche (median, 12.4 years; IQR, 11.9 to 13.2). Among eight C-LCAH-XX patients who underwent ultrasonography, three had unilocular ovarian cysts, including one rupture. Two NC-LCAH patients (p.Q258*/p.Val187Met and p.Ala218Val/p.Gly221Ser; both 46,XY) were diagnosed at 1.6 and 3.3 years with male external genitalia; one had spontaneous puberty at 10.6 years. Eight patients reached adult height (Z-score, 0.1; IQR, −0.9 to 1.2). The hydrocortisone dose was 21.7 mg/m2 (IQR, 14.9 to 26.5) at diagnosis and 17.3 mg/m2 (IQR, 13.9 to 22.7) at last follow-up (median age, 11.6 years; IQR, 8.9 to 17.4).Conclusion: This is the first large-scale multicenter investigation in Korea reporting long-term outcomes of LCAH. Continued longitudinal follow-up focusing on pubertal development and reproductive outcomes is warranted.
- 26 May 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (4) , 566-578
Open AccessClinical Characteristics and Outcomes of Korean Patients with Lipoid Congenital Adrenal Hyperplasia: An Analysis of Data from the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) Cohort Study
Background: Clinical characteristics and follow-up outcomes were examined in Korean patients with lipoid congenital adrenal hyperplasia (LCAH) enrolled in the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) cohort.Methods: Thirty-one patients (classic LCAH [C-LCAH], n=29; nonclassic LCAH [NC-LCAH], n=2) from 10 centers were included. NC-LCAH was defined by any of the following: 46,XY karyotype with male external genitalia, no fludrocortisone use, or diagnosis after infancy.Results: Median age at diagnosis was 36.5 days (interquartile range [IQR], 14.6 to 120.5); salt-wasting occurred in 58.6% of patients, and skin hyperpigmentation was the most common clinical feature (71%). All C-LCAH patients (STAR variants: p.Q258*/p.Q258* [n=27], p.Q258*/p.Arg182His [n=1], p.Q258*/p.Arg182Cys [n=1]; karyotypes: 46,XX [n=17], 46,XY [n=12]) were diagnosed in infancy with a female phenotype. Among C-LCAH patients with 46,XX, 11 had spontaneous thelarche (median, 11.0 years; IQR, 8.2 to 12.2) and five reached menarche (median, 12.4 years; IQR, 11.9 to 13.2). Among eight C-LCAH-XX patients who underwent ultrasonography, three had unilocular ovarian cysts, including one rupture. Two NC-LCAH patients (p.Q258*/p.Val187Met and p.Ala218Val/p.Gly221Ser; both 46,XY) were diagnosed at 1.6 and 3.3 years with male external genitalia; one had spontaneous puberty at 10.6 years. Eight patients reached adult height (Z-score, 0.1; IQR, −0.9 to 1.2). The hydrocortisone dose was 21.7 mg/m2 (IQR, 14.9 to 26.5) at diagnosis and 17.3 mg/m2 (IQR, 13.9 to 22.7) at last follow-up (median age, 11.6 years; IQR, 8.9 to 17.4).Conclusion: This is the first large-scale multicenter investigation in Korea reporting long-term outcomes of LCAH. Continued longitudinal follow-up focusing on pubertal development and reproductive outcomes is warranted.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e252761
Deep Learning–based Bone Mineral Density Prediction Using Pediatric Chest Radiographs: A Multicenter Feasibility Study
An artificial intelligence model using pediatric chest radiographs accurately detected low bone mineral density ( Z score ≤ −2.0) in internal and external test sets.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e252761
Deep Learning–based Bone Mineral Density Prediction Using Pediatric Chest Radiographs: A Multicenter Feasibility Study
An artificial intelligence model using pediatric chest radiographs accurately detected low bone mineral density ( Z score ≤ −2.0) in internal and external test sets.
- Open Access
- 28 February 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (1) , 45-54
Outcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents
Purpose: Despite the global paradigm emphasizing earlier and more aggressive intervention for youth-onset type 2 diabetes mellitus (T2DM), metformin and insulin are the only drugs approved for Korean adolescents. We investigated the incidence of complications, changes in glycemic control during the transition period, the effect of second-line antidiabetic agents on glycemic control in young adults with youth-onset T2DM.Methods: Eighty-four patients diagnosed with T2DM at Seoul National University Children's Hospital between January 2001 and July 2023, before age 18 (47 males; mean age, 14 years) with available glycated hemoglobin (HbA1c) data from at least 2 distinct ages between 19 and 22 years old were retrospectively enrolled.Results: At the last follow-up (mean age, 24.9 years; median follow-up, 9.6 years), complications were found in 33.7% (nephropathy, 25.3%; eye disease, 20.6%), and 83% required insulin or second-line agents. During the transition period, HbA1c levels decreased from 8.2% at age 19 to 7.7% at age 22 (P<0.01), with greater improvements in females, those diagnosed before age 15, and those with HbA1c levels ≥7% at age 19. HbA1c level decreased significantly at 1 year after the addition of second-line medications (P=0.03) and at the last visit (P=0.03) compared with baseline.Conclusion: Glycemic control improved during the transition period among youth-onset T2DM patients. Given the high incidence of complications and the beneficial effects of second-line agents on glycemic control, there is an urgent need to expand the range of approved second-line agents, along with broader insurance coverage in adolescence.
- 28 February 2026
- Published by Korean Society of Pediatric Endocrinology in Annals of Pediatric Endocrinology & Metabolism
- Vol. 31 (1) , 45-54
Open AccessOutcomes in youth-onset type 2 diabetes during the transition period: glycemic control, microvascular complications, and effects of second-line agents
Purpose: Despite the global paradigm emphasizing earlier and more aggressive intervention for youth-onset type 2 diabetes mellitus (T2DM), metformin and insulin are the only drugs approved for Korean adolescents. We investigated the incidence of complications, changes in glycemic control during the transition period, the effect of second-line antidiabetic agents on glycemic control in young adults with youth-onset T2DM.Methods: Eighty-four patients diagnosed with T2DM at Seoul National University Children's Hospital between January 2001 and July 2023, before age 18 (47 males; mean age, 14 years) with available glycated hemoglobin (HbA1c) data from at least 2 distinct ages between 19 and 22 years old were retrospectively enrolled.Results: At the last follow-up (mean age, 24.9 years; median follow-up, 9.6 years), complications were found in 33.7% (nephropathy, 25.3%; eye disease, 20.6%), and 83% required insulin or second-line agents. During the transition period, HbA1c levels decreased from 8.2% at age 19 to 7.7% at age 22 (P<0.01), with greater improvements in females, those diagnosed before age 15, and those with HbA1c levels ≥7% at age 19. HbA1c level decreased significantly at 1 year after the addition of second-line medications (P=0.03) and at the last visit (P=0.03) compared with baseline.Conclusion: Glycemic control improved during the transition period among youth-onset T2DM patients. Given the high incidence of complications and the beneficial effects of second-line agents on glycemic control, there is an urgent need to expand the range of approved second-line agents, along with broader insurance coverage in adolescence.
- Open Access
- 6 February 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 311, 119845
Early childhood blood lead concentrations and selective attention among school-age children: Evidence consistent with a causal association and effect modification by sleep duration
- 6 February 2026
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 311, 119845
Open AccessEarly childhood blood lead concentrations and selective attention among school-age children: Evidence consistent with a causal association and effect modification by sleep duration
- 22 January 2026
- Published by S. Karger AG in Hormone Research in Paediatrics
- p. 1-10
Trajectory of Glycemic Control from Late Adolescence to Young Adulthood with Type 1 Diabetes: A Longitudinal Study
Introduction: Improving outcomes for transition-aged patients with type 1 diabetes (T1D) requires understanding glycemic trajectories and modifiable factors. We evaluated longitudinal glycated hemoglobin (HbA1c) trends, target attainment, and associated factors in Korean youth with T1D. Methods: This retrospective cohort included 354 patients diagnosed before age 14 years with HbA1c data at three or more distinct ages between 15 and 22 years, followed at Seoul National University Children’s Hospital during 1999–2024. Linear mixed-effects models assessed factors associated with the HbA1c trajectory. Results: Mean HbA1c declined from 9.0% (75 mmol/mol) at the age of 15 years to 8.2% (66 mmol/mol) at the age of 22 years (−0.103% [−1.1 mmol/mol] per year, p < 0.001). Older age, male sex, continuous glucose monitoring (CGM) use, and parental college education were independently associated with lower HbA1c over time (all p < 0.05). At the age of 22 years, there were no CGM users in the 2006–2015 cohort, whereas 25.2% used CGM in the 2016–2024 cohort. At this age, 19.6% achieved HbA1c <7% (53 mmol/mol), whereas 24.8% remained at ≥9%. Among those with HbA1c ≥9% at the age of 15 years, nearly half remained ≥9% at the age of 22 years, while approximately one-tenth improved to <7%. Conclusions: Although glycemic control improved with age, a substantial proportion of adolescents and young adults with T1D failed to meet HbA1c targets. Given that CGM use was a key factor associated with better control, increasing CGM uptake alongside tailored support may improve outcomes during the transition to adulthood.
- 22 January 2026
- Published by S. Karger AG in Hormone Research in Paediatrics
- p. 1-10
Trajectory of Glycemic Control from Late Adolescence to Young Adulthood with Type 1 Diabetes: A Longitudinal Study
Introduction: Improving outcomes for transition-aged patients with type 1 diabetes (T1D) requires understanding glycemic trajectories and modifiable factors. We evaluated longitudinal glycated hemoglobin (HbA1c) trends, target attainment, and associated factors in Korean youth with T1D. Methods: This retrospective cohort included 354 patients diagnosed before age 14 years with HbA1c data at three or more distinct ages between 15 and 22 years, followed at Seoul National University Children’s Hospital during 1999–2024. Linear mixed-effects models assessed factors associated with the HbA1c trajectory. Results: Mean HbA1c declined from 9.0% (75 mmol/mol) at the age of 15 years to 8.2% (66 mmol/mol) at the age of 22 years (−0.103% [−1.1 mmol/mol] per year, p < 0.001). Older age, male sex, continuous glucose monitoring (CGM) use, and parental college education were independently associated with lower HbA1c over time (all p < 0.05). At the age of 22 years, there were no CGM users in the 2006–2015 cohort, whereas 25.2% used CGM in the 2016–2024 cohort. At this age, 19.6% achieved HbA1c <7% (53 mmol/mol), whereas 24.8% remained at ≥9%. Among those with HbA1c ≥9% at the age of 15 years, nearly half remained ≥9% at the age of 22 years, while approximately one-tenth improved to <7%. Conclusions: Although glycemic control improved with age, a substantial proportion of adolescents and young adults with T1D failed to meet HbA1c targets. Given that CGM use was a key factor associated with better control, increasing CGM uptake alongside tailored support may improve outcomes during the transition to adulthood.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (41)
Prevalence, Diagnostic Role, and Clinical Features of Zinc Transporter 8 Autoantibody in Korean Children and Adolescents With Diabetes Mellitus
Shin S, et al. J Korean Med Sci. 2026 Oct;41:e118. https://doi.org/10.3346/jkms.2026.41.e118
- 1 January 2026
- Published by XMLink in Journal of Korean Medical Science
- Vol. 41 (41)
Open AccessPrevalence, Diagnostic Role, and Clinical Features of Zinc Transporter 8 Autoantibody in Korean Children and Adolescents With Diabetes Mellitus
Shin S, et al. J Korean Med Sci. 2026 Oct;41:e118. https://doi.org/10.3346/jkms.2026.41.e118